$DVA Income Statement | Understand Stock

$DVA

$184.03 +$0.39 (0.21%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Dialysis patient service revenues
Other revenues
Total revenues
Operating expenses:
Patient care costs
General and administrative
Depreciation and amortization
Equity investment income, net
Goodwill impairment charges
Gain on changes in ownership interests
Total operating expenses
Operating income
Debt expense
Debt prepayment, refinancing and redemption charges
Debt extinguishment and modification costs
Other loss, net
Income from continuing operations before income taxes
Income tax expense
Net income from continuing operations
Net income from discontinued operations, net of tax
Net income
Less: Net income attributable to noncontrolling interests
Net income attributable to DaVita Inc.
Earnings per share attributable to DaVita Inc.:
Basic net income from continuing operations
Basic net income
Diluted net income from continuing operations
Diluted net income
Weighted average shares for earnings per share:
Basic shares (in shares)
Diluted shares (in shares)
Amounts attributable to DaVita Inc.:
Net income from continuing operations
Net income from discontinued operations

Comments